Ron Adelman, MD, MPH, MBA, FACS

Ron Adelman, MD, MPH, MBA, FACS
Accepting new patients? Yes
Referrals required? From patients or physicians
Patient type treated: Child; Adult; Older Adult
Board Certified in Ophthalmology

Ron Adelman, MD, MPH, MBA, is professor of ophthalmology and director of the Retina and Macula Service at Yale School of Medicine. He is an internationally recognized expert in diseases and surgery of the macula, retina, and vitreous.  

Dr. Adelman is the Scientific Director of European Vitreo-Retinal Society (EVRS), and the President-Elect of Connecticut State Medical Society (CSMS). He has served as President of the Connecticut Society of Eye Physicians and Surgeons (CSEP), and President of the New Haven County Medical Association (NHCMA). He has been an invited faculty in 15 countries including Germany, Italy, Australia, Spain, Mexico, and Canada. His clinical interests include macular holes and puckers, macular degeneration, diabetic retinopathy, complex retinal detachment, retinal vein occlusion, retinal laser, and surgery.  

He has received the “Senior Honor Award” of the American Society of Retina Specialists, the “Senior Achievement Award” of the American Academy of Ophthalmology, the “M Bruce Shields Teaching Award,” and multiple leadership awards. He has been recognized by the Lions of Connecticut as Knight of the Blind for “outstanding work throughout the state and in the global community.”  

Dr. Adelman’s education includes a Master of Public Health (MPH) from the University of California at Berkeley, an MBA from the Yale School of Management, an ophthalmology residency and a retina fellowship at the Massachusetts Eye and Ear Infirmary of Harvard Medical School. During his fellowship, he received many awards, including the Club Vit Fellow Research Award, the Ron G. Michels Fellowship Award, and Fellow of the Year 2000.  

He has been at the forefront of new advancements in macular and retinal diseases and has been Principal Investigator of numerous clinical trials. Dr. Adelman has published extensively, primarily in the area of retinal and macular diseases and surgery, with over 160 publications and 300 abstracts. He serves on the editorial board of the American Journal of Ophthalmology and several other scientific journals, and serves on the Executive Committees of several medical societies.    

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.